Constructive Bio was selected by Nature Biotechnology as a 2025 Editor’s Pick, recognising the company’s synthetic genomics platform and use…
Constructive Bio entered a collaboration with the Ellison Institute of Technology’s Generative Biology Institute (GBI) in Oxford, combining synthetic genome…
Constructive Bio hosted the Cambridge iGEM 2025 team at The Recodery for a technical discussion on synthetic biology research, as…
Constructive Bio won the Life Science Scale-Up Award at the 35th Anniversary Business Weekly Awards in Cambridge, recognising the company’s…
Constructive Bio is contributing its large-scale genome assembly platform to an ARIA-funded collaboration with Camena Bioscience and the Max-Planck Institute…
The New York Times covered the creation of Syn57, an E. coli strain with a 57-codon synthetic genome — the…
Constructive Bio sponsored the 2025 LMB–Institut Pasteur Symposium at the MRC Laboratory of Molecular Biology in Cambridge, bringing together international…
Constructive Bio was Highly Commended in the Biotech Company of the Year category at the Cambridge Independent Science and Technology…
Constructive Bio founder and CSO Professor Jason Chin received the SynBioBeta 2025 Impact Award, recognising his contributions to synthetic biology…
The Sunday Times named Constructive Bio a ‘Biotech One to Watch’ in its 2025 100 Tech Awards, recognising the Cambridge-based…
Engineering the future of biology with revolutionary genome synthesis and expanded genetic code technology.
QUICK LINKS
JOIN OUR NEWSLETTER
© 2026 Constructive Bio. All rights reserved.